logo
Probabilistic Analysis of Cost-Effectiveness Models
Growth and Quality of the Cost–Utility Literature, 1976–2001
Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe
An Evaluation of Managing and Educating Patients on the Risk of Glucocorticoid-Induced Osteoporosis
Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries
Effect of Outpatient Treatment of Febrile Neutropenia on the Risk Threshold for the Use of CSF in Patients with Cancer Treated with Chemotherapy
An Assessment of the Impact of Informative Dropout and Nonresponse in Measuring Health-Related Quality of Life Using the EuroQol (EQ-5D) Descriptive System
Development and Initial Validation of an Instrument to Measure Physician–Pharmacist Collaboration from the Physician Perspective
Collection of Health-Economic Data Alongside Clinical Trials
Some Considerations for the Interpretation of Health-Related Quality of Life Data
Needs-Based Health-Related Quality of Life Measurement
Needs-Based Quality of Life (QoL)
Thresholds in Cost-Effectiveness Analysis—More of the Story